Ann: Upcoming Release of Shares from Escrow, page-82

Having an Ag background, this one piqued my interest at IPO but just hung back as I thought it was priced a little too expensive (relative to an ASX investor base, who wouldn't understand/appreciate the work being done).

Huge R&D spent each year on discovering the next generation of pest and crop agents. The main issue in this industry is lead times from R&D and trials to commercialisation. I liken it almost to the pharmaceutical industry because change takes a long time. But as with techs/bios, we don't need to see revenue ticking in to make money.

Anyway, bought an opening parcel to have some skin in the game, will add a few more on any weakness and be watching how that escrow (and any tax loss selling) is managed in a week's time. Shaw and D2MX just slaughtering the stock atm. Difficult and almost silly for a LM or interested parties to step-up on-market when the selling is so motivated, only issue is it can make it hard to rally on the way back up.